Peptide Blog
Articles, dosing guides, and expert insights on peptides and their real-world applications.
Articles, dosing guides, and expert insights on peptides and their real-world applications.
Rep. Nancy Mace introduced the PEPTIDES for Veterans Act on September 1, 2026, ordering the VA to study peptide therapies and run a voluntary pilot. What the bill does, what the evidence shows, and what veterans can legally access today.
CagriSema vs retatrutide in 2026: 22.7% vs 28.3% weight loss, why the two phase 3 trials are not comparable, and the tirzepatide bridge that settles it.
Minoxidil for women: which strength is FDA-approved, how long results take, the shedding phase explained, side effects, and what happens when you stop.
Best peptides affiliate programs for 2026. Why lifetime commission beats a higher first-order rate, real earnings scenarios, payout speed, and how to negotiate up.
FDA advisers backed BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax while rejecting Emideltide/DSIP. See every tally, what the non-binding recommendations mean, and what FDA does next.
Eli Lilly’s latest retatrutide Phase 3 results show up to 22.6% average weight loss in TRIUMPH-3 and 20.8% in TRIUMPH-2. Here is what the topline data, cardiovascular findings, side effects, and planned Q1 2027 FDA filing mean.
Reader discount
99%+ purity research peptides — third-party tested, COA included
Save 50% with code PEPTIDEDECK
MEDVi reviews 2026: 4.4/5 on Trustpilot but an F rating and 668 complaints at the BBB. Real pricing ($179 then $299), patient results, the FDA letter, and how to cancel.
How to increase IGF-1 naturally with protein, resistance training, deep sleep and key nutrients, backed by what human studies actually show (2026).
An honest, current guide to HRT for women: the two main types, real risk numbers, the 2025 FDA warning change, who it fits by age, alternatives, and how to get it.
MOTS-c and SS-31 are both called mitochondrial peptides, but they do nearly opposite things: MOTS-c signals cells to act like they are exercising, while SS-31 (elamipretide) physically repairs the inner mitochondrial membrane. This guide compares mechanism, evidence, dosing, and safety, including SS-31's landmark 2025 FDA approval.